25 XP   0   0   10

Xencor Inc
Buy, Hold or Sell?

Let's analyse Xencor together

PenkeI guess you are interested in Xencor Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Xencor Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Xencor Inc

I send you an email if I find something interesting about Xencor Inc.

Quick analysis of Xencor (30 sec.)










What can you expect buying and holding a share of Xencor? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$10.85
Expected worth in 1 year
$7.07
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-3.79
Return On Investment
-15.7%

For what price can you sell your share?

Current Price per Share
$24.11
Expected price per share
$16.49 - $26.84
How sure are you?
50%

1. Valuation of Xencor (5 min.)




Live pricePrice per Share (EOD)

$24.11

Intrinsic Value Per Share

$0.34 - $5.30

Total Value Per Share

$11.19 - $16.15

2. Growth of Xencor (5 min.)




Is Xencor growing?

Current yearPrevious yearGrowGrow %
How rich?$669.1m$727.4m-$58.3m-8.7%

How much money is Xencor making?

Current yearPrevious yearGrowGrow %
Making money-$126m-$55.1m-$70.9m-56.2%
Net Profit Margin-74.9%-33.5%--

How much money comes from the company's main activities?

3. Financial Health of Xencor (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#82 / 1007

Most Revenue
#161 / 1007

Most Profit
#820 / 1007

Most Efficient
#562 / 1007

What can you expect buying and holding a share of Xencor? (5 min.)

Welcome investor! Xencor's management wants to use your money to grow the business. In return you get a share of Xencor.

What can you expect buying and holding a share of Xencor?

First you should know what it really means to hold a share of Xencor. And how you can make/lose money.

Speculation

The Price per Share of Xencor is $24.11. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Xencor.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Xencor, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.85. Based on the TTM, the Book Value Change Per Share is $-0.95 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Xencor.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.05-8.5%-2.05-8.5%-0.90-3.7%-0.46-1.9%-0.44-1.8%
Usd Book Value Change Per Share-0.95-3.9%-0.95-3.9%-0.10-0.4%0.482.0%0.974.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.95-3.9%-0.95-3.9%-0.10-0.4%0.482.0%0.974.0%
Usd Price Per Share21.23-21.23-26.04-33.08-28.05-
Price to Earnings Ratio-10.38--10.38--29.09-6.11--7.15-
Price-to-Total Gains Ratio-22.42--22.42--267.19--74.84--45.72-
Price to Book Ratio1.96-1.96-2.21-3.16-5.23-
Price-to-Total Gains Ratio-22.42--22.42--267.19--74.84--45.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share24.11
Number of shares41
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.950.48
Usd Total Gains Per Share-0.950.48
Gains per Quarter (41 shares)-38.8219.61
Gains per Year (41 shares)-155.2678.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-155-16507868
20-311-3200157146
30-466-4750235224
40-621-6300314302
50-776-7850392380
60-932-9400471458
70-1087-10950549536
80-1242-12500628614
90-1397-14050706692
100-1553-15600785770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%3.010.00.023.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%6.07.00.046.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%6.07.00.046.2%

Fundamentals of Xencor

About Xencor Inc

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. It develops Plamotamab, a bispecific antibody, which is in Phase I clinical trial to treat non-Hodgkin lymphoma; Vudalimab, a bispecific antibody, which is in Phase II clinical trial to treat metastatic castration-resistant prostate cancer and other solid tumor types. The company is also developing XmAb306, which is in Phase I clinical trial to treat solid tumors; XmAb104, which is in Phase II clinical trial to treat patients with selected solid tumors; XmAb564 that is in Phase Ia clinical trial to treat autoimmune diseases; AMG 509, which is in Phase I clinical trial to treat prostate cancer; XmAb819 for patients with renal cell carcinoma; XmAb541 for the treatment of ovarian cancer; and XmAb662 which is in Phase I clinical trial to treat patients with solid tumors. In addition, the company develops VIR-3434, which is in Phase II clinical trial for patients with hepatitis B virus infection; and VIR-2482 that is in Phase 2 clinical trial to trat hepatitis B virus. The company develops AIMab7195 to reduce blood serum levels of IgE that mediates allergic responses and allergic disease; Obexelimab to treat autoimmune disease; and Xpro1595 to treat patients with Alzheimer's disease, and depression. It has a license agreement with Caris Life Sciences. Xencor, Inc. was incorporated in 1997 and is headquartered in Pasadena, California.

Fundamental data was last updated by Penke on 2024-04-30 19:18:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Xencor Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Xencor earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • A Net Profit Margin of -74.9% means that $-0.75 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Xencor Inc:

  • The MRQ is -74.9%. The company is making a huge loss. -2
  • The TTM is -74.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-74.9%TTM-74.9%0.0%
TTM-74.9%YOY-33.5%-41.4%
TTM-74.9%5Y-22.6%-52.3%
5Y-22.6%10Y-63.2%+40.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-74.9%-207.2%+132.3%
TTM-74.9%-216.8%+141.9%
YOY-33.5%-282.4%+248.9%
5Y-22.6%-426.4%+403.8%
10Y-63.2%-589.3%+526.1%
1.1.2. Return on Assets

Shows how efficient Xencor is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • -13.2% Return on Assets means that Xencor generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Xencor Inc:

  • The MRQ is -13.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.2%TTM-13.2%0.0%
TTM-13.2%YOY-6.5%-6.7%
TTM-13.2%5Y-3.0%-10.3%
5Y-3.0%10Y-6.7%+3.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.0%-0.2%
TTM-13.2%-12.5%-0.7%
YOY-6.5%-11.2%+4.7%
5Y-3.0%-13.6%+10.6%
10Y-6.7%-15.2%+8.5%
1.1.3. Return on Equity

Shows how efficient Xencor is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • -18.9% Return on Equity means Xencor generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Xencor Inc:

  • The MRQ is -18.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.9%TTM-18.9%0.0%
TTM-18.9%YOY-7.6%-11.3%
TTM-18.9%5Y-4.3%-14.5%
5Y-4.3%10Y-8.4%+4.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.9%-16.6%-2.3%
TTM-18.9%-15.7%-3.2%
YOY-7.6%-14.2%+6.6%
5Y-4.3%-18.9%+14.6%
10Y-8.4%-19.9%+11.5%

1.2. Operating Efficiency of Xencor Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Xencor is operating .

  • Measures how much profit Xencor makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • An Operating Margin of -82.4% means the company generated $-0.82  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Xencor Inc:

  • The MRQ is -82.4%. The company is operating very inefficient. -2
  • The TTM is -82.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-82.4%TTM-82.4%0.0%
TTM-82.4%YOY-50.1%-32.2%
TTM-82.4%5Y-34.6%-47.7%
5Y-34.6%10Y-74.1%+39.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-82.4%-285.4%+203.0%
TTM-82.4%-226.2%+143.8%
YOY-50.1%-288.4%+238.3%
5Y-34.6%-469.6%+435.0%
10Y-74.1%-599.3%+525.2%
1.2.2. Operating Ratio

Measures how efficient Xencor is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.82 means that the operating costs are $1.82 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Xencor Inc:

  • The MRQ is 1.824. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.824. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.824TTM1.8240.000
TTM1.824YOY1.555+0.269
TTM1.8245Y1.785+0.039
5Y1.78510Y2.838-1.053
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8243.231-1.407
TTM1.8243.303-1.479
YOY1.5553.763-2.208
5Y1.7855.586-3.801
10Y2.8387.464-4.626

1.3. Liquidity of Xencor Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Xencor is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.36 means the company has $7.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Xencor Inc:

  • The MRQ is 7.356. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.356. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.356TTM7.3560.000
TTM7.356YOY10.578-3.222
TTM7.3565Y7.518-0.162
5Y7.51810Y5.863+1.655
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3563.855+3.501
TTM7.3564.160+3.196
YOY10.5785.323+5.255
5Y7.5186.122+1.396
10Y5.8636.480-0.617
1.3.2. Quick Ratio

Measures if Xencor is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • A Quick Ratio of 13.52 means the company can pay off $13.52 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Xencor Inc:

  • The MRQ is 13.516. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.516. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ13.516TTM13.5160.000
TTM13.516YOY19.128-5.611
TTM13.5165Y13.061+0.455
5Y13.06110Y9.607+3.454
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.5163.506+10.010
TTM13.5164.001+9.515
YOY19.1285.390+13.738
5Y13.0616.127+6.934
10Y9.6076.488+3.119

1.4. Solvency of Xencor Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Xencor assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Xencor to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.30 means that Xencor assets are financed with 29.8% credit (debt) and the remaining percentage (100% - 29.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Xencor Inc:

  • The MRQ is 0.298. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.298. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.298TTM0.2980.000
TTM0.298YOY0.140+0.157
TTM0.2985Y0.173+0.125
5Y0.17310Y0.184-0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2980.344-0.046
TTM0.2980.339-0.041
YOY0.1400.275-0.135
5Y0.1730.368-0.195
10Y0.1840.389-0.205
1.4.2. Debt to Equity Ratio

Measures if Xencor is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • A Debt to Equity ratio of 42.4% means that company has $0.42 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Xencor Inc:

  • The MRQ is 0.424. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.424. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.424TTM0.4240.000
TTM0.424YOY0.163+0.261
TTM0.4245Y0.218+0.206
5Y0.21810Y0.236-0.018
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4240.390+0.034
TTM0.4240.408+0.016
YOY0.1630.341-0.178
5Y0.2180.438-0.220
10Y0.2360.469-0.233

2. Market Valuation of Xencor Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Xencor generates.

  • Above 15 is considered overpriced but always compare Xencor to the Biotechnology industry mean.
  • A PE ratio of -10.38 means the investor is paying $-10.38 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Xencor Inc:

  • The EOD is -11.788. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.380. Based on the earnings, the company is expensive. -2
  • The TTM is -10.380. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.788MRQ-10.380-1.408
MRQ-10.380TTM-10.3800.000
TTM-10.380YOY-29.092+18.712
TTM-10.3805Y6.111-16.490
5Y6.11110Y-7.149+13.260
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.788-2.351-9.437
MRQ-10.380-2.599-7.781
TTM-10.380-2.762-7.618
YOY-29.092-4.025-25.067
5Y6.111-6.305+12.416
10Y-7.149-6.538-0.611
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Xencor Inc:

  • The EOD is 23.275. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 20.494. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 20.494. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD23.275MRQ20.494+2.780
MRQ20.494TTM20.4940.000
TTM20.494YOY-84.851+105.346
TTM20.4945Y-48.643+69.138
5Y-48.64310Y-28.620-20.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD23.275-3.010+26.285
MRQ20.494-3.306+23.800
TTM20.494-3.607+24.101
YOY-84.851-5.524-79.327
5Y-48.643-8.299-40.344
10Y-28.620-8.910-19.710
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Xencor is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.96 means the investor is paying $1.96 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Xencor Inc:

  • The EOD is 2.221. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.956. Based on the equity, the company is underpriced. +1
  • The TTM is 1.956. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.221MRQ1.956+0.265
MRQ1.956TTM1.9560.000
TTM1.956YOY2.207-0.251
TTM1.9565Y3.161-1.205
5Y3.16110Y5.227-2.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.2212.019+0.202
MRQ1.9562.116-0.160
TTM1.9562.099-0.143
YOY2.2072.873-0.666
5Y3.1613.556-0.395
10Y5.2273.946+1.281
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Xencor Inc.

3.1. Institutions holding Xencor Inc

Institutions are holding 104.782% of the shares of Xencor Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc18.52170.0061113233108735078.3591
2023-12-31PRIMECAP Management Company14.56040.149689016077174018.7657
2023-12-31Vanguard Group Inc11.06930.003167672491158861.7423
2023-12-31EcoR1 Capital, LLC8.64072.9118528251600
2023-12-31T. Rowe Price Associates, Inc.5.69840.009934837752988419.383
2023-12-31State Street Corporation5.44180.0034332685634825511.6919
2023-12-31FMR Inc4.19220.00422562905-868990-25.321
2023-12-31Armistice Capital, LLC2.45360.43471500000220001.4885
2023-12-31T. Rowe Price Investment Management,Inc.2.21040.01871351367-2426996-64.2341
2023-12-31Geode Capital Management, LLC2.15090.00291314943549914.3645
2023-12-31Dimensional Fund Advisors, Inc.2.09220.00791279077-172270-11.8697
2023-12-31Loomis, Sayles & Company LP1.61650.0321988244-518308-34.4036
2023-12-31Goldman Sachs Group Inc1.43260.0017875800692437377.6318
2023-12-31Johnson & Johnson1.22360.362174806200
2023-12-31Morgan Stanley - Brokerage Accounts1.21870.001474504719342735.0653
2023-12-31Northern Trust Corp1.17590.0028718919446256.618
2023-12-31Candriam Luxembourg S.C.A.1.15810.1038707984550008.4229
2023-12-31Charles Schwab Investment Management Inc0.85170.0028520698322516.6028
2023-12-31Bank of New York Mellon Corp0.83230.0022508851229584.7249
2023-12-31JPMorgan Chase & Co0.81980.001501167-3417-0.6772
Total 87.36084.062253408377-518402-1.0%

3.2. Funds holding Xencor Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31PRIMECAP Odyssey Aggressive Growth9.32611.684257015871065601.9045
2024-03-28iShares Core S&P Small-Cap ETF6.7260.11334111968-15272-0.37
2023-12-31PRIMECAP Odyssey Growth3.86180.7318236094038737119.6279
2024-03-31SPDR® S&P Biotech ETF3.14260.561921264102510.5364
2024-03-31Vanguard Total Stock Mkt Idx Inv3.13550.00271916927126770.6657
2024-03-31Vanguard Small Cap Index2.54510.02341555982-13110-0.8355
2024-03-31US Small-Cap Growth II Equity Comp2.49170.13361523315990596.9551
2024-03-31T. Rowe Price New Horizons2.49170.13361523315990596.9551
2024-03-28iShares Russell 2000 ETF2.31740.047914167746840.0483
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr1.50790.0194921887133621.4707
2024-03-31Vanguard Small Cap Growth Index Inv1.4380.0535879141-1636-0.1857
2024-03-31T. Rowe Price Health Sciences1.37140.120483841313917219.9033
2023-12-31Vanguard US Opportunities Ins USD Acc1.06221.099664938582001.2789
2024-01-31Fidelity Small Cap Index0.95180.043958186167421.1723
2024-02-29Loomis Sayles Small Cap Growth Instl0.91230.5583557744-15007-2.6202
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.89250.11485456435500.1009
2023-12-31UBS: US Equity Small Cap Growth0.87580.466753539700
2024-03-31Vanguard Tax-Managed Small Cap Adm0.770.1146470756-4607-0.9692
2024-03-31T. Rowe Price Integrated US Sm Gr Eq0.76680.122546880000
2024-03-28iShares Biotechnology ETF0.72670.1288444260-3414-0.7626
Total 47.31336.27328925359+830641+2.9%

3.3. Insider Transactions

Insiders are holding 0.945% of the shares of Xencor Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-11Bassil I DahiyatSELL274123.5
2024-03-11Celia EckertSELL85023.5
2024-03-11John J KuchSELL84923.5
2024-03-11John R DesjarlaisSELL128023.5
2024-03-06Kurt A GustafsonSELL1400023.18
2024-03-05Bassil I DahiyatSELL1252823.43
2024-03-05Celia EckertSELL389223.43
2024-03-05John J KuchSELL447423.43
2024-03-05John R DesjarlaisSELL662923.43
2024-02-13John R DesjarlaisSELL5410819.38
2023-12-29Bassil I DahiyatSELL4500020.93
2023-06-21Bassil I DahiyatSELL3349726.19

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Xencor Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.947-0.9470%-0.097-90%0.478-298%0.966-198%
Book Value Per Share--10.85410.8540%11.801-8%10.692+2%7.519+44%
Current Ratio--7.3567.3560%10.578-30%7.518-2%5.863+25%
Debt To Asset Ratio--0.2980.2980%0.140+112%0.173+72%0.184+61%
Debt To Equity Ratio--0.4240.4240%0.163+160%0.218+95%0.236+80%
Dividend Per Share----0%-0%-0%-0%
Eps---2.045-2.0450%-0.895-56%-0.458-78%-0.439-79%
Free Cash Flow Per Share--1.0361.0360%-0.307+130%0.151+584%0.013+8119%
Free Cash Flow To Equity Per Share--1.4521.4520%-0.214+115%0.486+199%0.984+48%
Gross Profit Margin--1.0911.0910%1.000+9%1.018+7%1.009+8%
Intrinsic Value_10Y_max--5.298--------
Intrinsic Value_10Y_min--0.339--------
Intrinsic Value_1Y_max--0.234--------
Intrinsic Value_1Y_min--0.018--------
Intrinsic Value_3Y_max--0.929--------
Intrinsic Value_3Y_min--0.069--------
Intrinsic Value_5Y_max--1.897--------
Intrinsic Value_5Y_min--0.134--------
Market Cap1486321225.000+12%1308776425.0001308776425.0000%1605300900.000-18%2039422595.000-36%1729027432.500-24%
Net Profit Margin---0.749-0.7490%-0.335-55%-0.226-70%-0.632-16%
Operating Margin---0.824-0.8240%-0.501-39%-0.346-58%-0.741-10%
Operating Ratio--1.8241.8240%1.555+17%1.785+2%2.838-36%
Pb Ratio2.221+12%1.9561.9560%2.207-11%3.161-38%5.227-63%
Pe Ratio-11.788-14%-10.380-10.3800%-29.092+180%6.111-270%-7.149-31%
Price Per Share24.110+12%21.23021.2300%26.040-18%33.082-36%28.047-24%
Price To Free Cash Flow Ratio23.275+12%20.49420.4940%-84.851+514%-48.643+337%-28.620+240%
Price To Total Gains Ratio-25.467-14%-22.425-22.4250%-267.194+1092%-74.840+234%-45.722+104%
Quick Ratio--13.51613.5160%19.128-29%13.061+3%9.607+41%
Return On Assets---0.132-0.1320%-0.065-51%-0.030-77%-0.067-49%
Return On Equity---0.189-0.1890%-0.076-60%-0.043-77%-0.084-56%
Total Gains Per Share---0.947-0.9470%-0.097-90%0.478-298%0.966-198%
Usd Book Value--669133000.000669133000.0000%727496000.000-8%659155600.000+2%463518100.000+44%
Usd Book Value Change Per Share---0.947-0.9470%-0.097-90%0.478-298%0.966-198%
Usd Book Value Per Share--10.85410.8540%11.801-8%10.692+2%7.519+44%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---2.045-2.0450%-0.895-56%-0.458-78%-0.439-79%
Usd Free Cash Flow--63860000.00063860000.0000%-18919000.000+130%9334200.000+584%777000.000+8119%
Usd Free Cash Flow Per Share--1.0361.0360%-0.307+130%0.151+584%0.013+8119%
Usd Free Cash Flow To Equity Per Share--1.4521.4520%-0.214+115%0.486+199%0.984+48%
Usd Market Cap1486321225.000+12%1308776425.0001308776425.0000%1605300900.000-18%2039422595.000-36%1729027432.500-24%
Usd Price Per Share24.110+12%21.23021.2300%26.040-18%33.082-36%28.047-24%
Usd Profit---126087000.000-126087000.0000%-55181000.000-56%-27060200.000-79%-26502400.000-79%
Usd Revenue--168338000.000168338000.0000%164579000.000+2%177484400.000-5%108853800.000+55%
Usd Total Gains Per Share---0.947-0.9470%-0.097-90%0.478-298%0.966-198%
 EOD+4 -4MRQTTM+0 -0YOY+10 -245Y+14 -2010Y+17 -17

4.2. Fundamental Score

Let's check the fundamental score of Xencor Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.788
Price to Book Ratio (EOD)Between0-12.221
Net Profit Margin (MRQ)Greater than0-0.749
Operating Margin (MRQ)Greater than0-0.824
Quick Ratio (MRQ)Greater than113.516
Current Ratio (MRQ)Greater than17.356
Debt to Asset Ratio (MRQ)Less than10.298
Debt to Equity Ratio (MRQ)Less than10.424
Return on Equity (MRQ)Greater than0.15-0.189
Return on Assets (MRQ)Greater than0.05-0.132
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Xencor Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.979
Ma 20Greater thanMa 5020.412
Ma 50Greater thanMa 10021.930
Ma 100Greater thanMa 20021.240
OpenGreater thanClose24.260
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets952,692
Total Liabilities283,559
Total Stockholder Equity668,796
 As reported
Total Liabilities 283,559
Total Stockholder Equity+ 668,796
Total Assets = 952,692

Assets

Total Assets952,692
Total Current Assets623,160
Long-term Assets329,532
Total Current Assets
Cash And Cash Equivalents 53,790
Short-term Investments 539,935
Net Receivables 11,290
Other Current Assets 18,145
Total Current Assets  (as reported)623,160
Total Current Assets  (calculated)623,160
+/-0
Long-term Assets
Property Plant Equipment 100,119
Long Term Investments 209,722
Intangible Assets 18,663
Long-term Assets  (as reported)329,532
Long-term Assets  (calculated)328,504
+/- 1,028

Liabilities & Shareholders' Equity

Total Current Liabilities84,709
Long-term Liabilities198,850
Total Stockholder Equity668,796
Total Current Liabilities
Short-term Debt 9,767
Short Long Term Debt 6,332
Accounts payable 13,914
Other Current Liabilities 29,346
Total Current Liabilities  (as reported)84,709
Total Current Liabilities  (calculated)59,359
+/- 25,350
Long-term Liabilities
Long term Debt 14,642
Capital Lease Obligations 62,460
Long-term Liabilities  (as reported)198,850
Long-term Liabilities  (calculated)77,102
+/- 121,748
Total Stockholder Equity
Common Stock611
Retained Earnings -464,372
Accumulated Other Comprehensive Income 1,291
Other Stockholders Equity 1,130,929
Total Stockholder Equity (as reported)668,796
Total Stockholder Equity (calculated)668,459
+/- 337
Other
Capital Stock611
Cash and Short Term Investments 593,725
Common Stock Shares Outstanding 60,503
Current Deferred Revenue31,682
Liabilities and Stockholders Equity 952,692
Net Debt 29,644
Net Invested Capital 689,770
Net Working Capital 538,451
Property Plant and Equipment Gross 136,345
Short Long Term Debt Total 83,434



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
22,374
11,659
87,315
67,823
206,910
428,563
390,102
576,732
670,250
703,244
838,211
846,266
952,692
952,692846,266838,211703,244670,250576,732390,102428,563206,91067,82387,31511,65922,374
   > Total Current Assets 
14,647
2,839
78,094
57,749
97,675
141,653
230,879
315,727
558,405
637,672
424,368
675,342
623,160
623,160675,342424,368637,672558,405315,727230,879141,65397,67557,74978,0942,83914,647
       Cash And Cash Equivalents 
14,537
2,312
77,975
54,649
12,590
14,528
16,528
26,246
50,312
163,544
143,480
53,942
53,790
53,79053,942143,480163,54450,31226,24616,52814,52812,59054,64977,9752,31214,537
       Short-term Investments 
0
0
0
0
83,840
115,608
207,603
268,115
479,470
439,459
190,627
569,120
539,935
539,935569,120190,627439,459479,470268,115207,603115,60883,8400000
       Net Receivables 
29
354
59
2,966
44
8,616
1,142
10,991
22,076
23,943
66,384
28,997
11,290
11,29028,99766,38423,94322,07610,9911,1428,616442,9665935429
       Other Current Assets 
81
173
119
3,100
1,245
2,901
5,606
10,375
6,547
10,726
60,737
23,283
18,145
18,14523,28360,73710,7266,54710,3755,6062,9011,2453,10011917381
   > Long-term Assets 
7,727
8,820
9,221
10,074
109,235
286,910
159,223
261,005
111,845
65,572
413,843
170,924
329,532
329,532170,924413,84365,572111,845261,005159,223286,910109,23510,0749,2218,8207,727
       Property Plant Equipment 
384
283
307
899
2,310
3,105
7,088
11,813
25,185
32,282
59,970
93,602
100,119
100,11993,60259,97032,28225,18511,8137,0883,1052,310899307283384
       Long Term Investments 
0
0
0
0
96,891
273,340
140,722
236,912
71,928
17,101
331,727
58,209
209,722
209,72258,209331,72717,10171,928236,912140,722273,34096,8910000
       Intangible Assets 
7,250
8,460
8,814
9,116
9,971
10,362
11,148
11,969
14,421
15,977
16,493
18,500
18,663
18,66318,50016,49315,97714,42111,96911,14810,3629,9719,1168,8148,4607,250
       Long-term Assets Other 
93
77
100
59
63
103
265
311
311
212
653
613
119,430
119,43061365321231131126510363591007793
> Total Liabilities 
33,311
31,161
13,781
8,533
44,478
114,609
108,056
55,051
77,049
130,800
104,707
118,770
283,559
283,559118,770104,707130,80077,04955,051108,056114,60944,4788,53313,78131,16133,311
   > Total Current Liabilities 
26,197
25,479
7,479
6,196
43,429
106,286
101,345
53,853
66,558
121,061
70,738
63,844
84,709
84,70963,84470,738121,06166,55853,853101,345106,28643,4296,1967,47925,47926,197
       Short-term Debt 
18,473
20,930
9
0
0
6,692
5,480
9,662
2,169
1,889
33,969
4,708
9,767
9,7674,70833,9691,8892,1699,6625,4806,69200920,93018,473
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
6,332
6,332000000000000
       Accounts payable 
1,835
1,315
2,633
1,691
6,400
3,880
6,869
3,797
10,189
8,954
14,001
10,088
13,914
13,91410,08814,0018,95410,1893,7976,8693,8806,4001,6912,6331,3151,835
       Other Current Liabilities 
826
1,286
1,393
2,251
3,742
193
183
315
8,995
17,603
19,443
18,728
29,346
29,34618,72819,44317,6038,9953151831933,7422,2511,3931,286826
   > Long-term Liabilities 
7,114
5,682
6,302
2,337
1,049
8,323
6,711
1,198
10,491
9,739
33,969
54,926
198,850
198,85054,92633,9699,73910,4911,1986,7118,3231,0492,3376,3025,6827,114
       Other Liabilities 
0
5,672
6,302
2,337
1,049
8,323
1,088
1,198
1,926
0
0
0
0
00001,9261,1981,0888,3231,0492,3376,3025,6720
       Deferred Long Term Liability 
0
0
0
2,337
1,049
8,323
6,711
1,198
0
0
0
0
0
000001,1986,7118,3231,0492,337000
> Total Stockholder Equity
-10,937
-19,502
73,534
59,290
162,432
313,954
282,046
521,681
593,201
572,444
733,504
727,496
668,796
668,796727,496733,504572,444593,201521,681282,046313,954162,43259,29073,534-19,502-10,937
   Common Stock
1
1
314
314
405
466
470
563
569
580
595
601
611
61160159558056956347046640531431411
   Retained Earnings Total Equity00-283,104-365,735-296,402-323,277-287,286-237,960-261,585-243,993000
   Accumulated Other Comprehensive Income 
-7,399
-6,279
-6,377
-6,554
-516
-1,441
-1,808
-971
1,161
74
-1,510
-6,952
1,291
1,291-6,952-1,510741,161-971-1,808-1,441-516-6,554-6,377-6,279-7,399
   Capital Surplus 
0
0
0
302,969
424,128
552,889
570,670
845,366
887,873
937,525
1,017,523
0
0
001,017,523937,525887,873845,366570,670552,889424,128302,969000
   Treasury Stock0000000000000
   Other Stockholders Equity 
8,413
7,322
307,167
309,523
424,128
552,889
570,670
845,366
887,873
937,525
1,017,523
1,072,132
1,130,929
1,130,9291,072,1321,017,523937,525887,873845,366570,670552,889424,128309,523307,1677,3228,413



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue168,338
Cost of Revenue-11,498
Gross Profit156,840156,840
 
Operating Income (+$)
Gross Profit156,840
Operating Expense-295,479
Operating Income-138,639-138,639
 
Operating Expense (+$)
Research Development253,598
Selling General Administrative53,379
Selling And Marketing Expenses11,498
Operating Expense295,479318,475
 
Net Interest Income (+$)
Interest Income13,740
Interest Expense-0
Other Finance Cost-0
Net Interest Income13,740
 
Pretax Income (+$)
Operating Income-138,639
Net Interest Income13,740
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-120,439-156,839
EBIT - interestExpense = -138,639
-120,276
-126,087
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-138,639-120,439
Earnings Before Interest and Taxes (EBITDA)-127,141
 
After tax Income (+$)
Income Before Tax-120,439
Tax Provision--415
Net Income From Continuing Ops-119,028-120,024
Net Income-126,087
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses306,977
Total Other Income/Expenses Net18,200-13,740
 

Technical Analysis of Xencor
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Xencor. The general trend of Xencor is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Xencor's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Xencor Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 24.45 < 26.22 < 26.84.

The bearish price targets are: 17.95 > 17.82 > 16.49.

Tweet this
Xencor Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Xencor Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Xencor Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Xencor Inc. The current macd is 0.36829577.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Xencor price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Xencor. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Xencor price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Xencor Inc Daily Moving Average Convergence/Divergence (MACD) ChartXencor Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Xencor Inc. The current adx is 29.65.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Xencor shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Xencor Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Xencor Inc. The current sar is 18.89.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Xencor Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Xencor Inc. The current rsi is 68.98. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Xencor Inc Daily Relative Strength Index (RSI) ChartXencor Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Xencor Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Xencor price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Xencor Inc Daily Stochastic Oscillator ChartXencor Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Xencor Inc. The current cci is 202.39.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Xencor Inc Daily Commodity Channel Index (CCI) ChartXencor Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Xencor Inc. The current cmo is 54.95.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Xencor Inc Daily Chande Momentum Oscillator (CMO) ChartXencor Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Xencor Inc. The current willr is -13.71588523.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Xencor Inc Daily Williams %R ChartXencor Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Xencor Inc.

Xencor Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Xencor Inc. The current atr is 1.25055855.

Xencor Inc Daily Average True Range (ATR) ChartXencor Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Xencor Inc. The current obv is -560,910.

Xencor Inc Daily On-Balance Volume (OBV) ChartXencor Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Xencor Inc. The current mfi is 79.02.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Xencor Inc Daily Money Flow Index (MFI) ChartXencor Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Xencor Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Xencor Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Xencor Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.979
Ma 20Greater thanMa 5020.412
Ma 50Greater thanMa 10021.930
Ma 100Greater thanMa 20021.240
OpenGreater thanClose24.260
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Xencor with someone you think should read this too:
  • Are you bullish or bearish on Xencor? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Xencor? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Xencor Inc

I send you an email if I find something interesting about Xencor Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Xencor Inc.

Receive notifications about Xencor Inc in your mailbox!